M
MannKind Corp D
D
MNKD
3.59500
USD
-0.03
(-0.69%)
مغلق
حجم التداول
28,500
الربح لكل سهم
0
العائد الربحي
-
P/E
36
حجم السوق
1,092,638,603
الأخبار المقالات
العنوان: MannKind Corp
القطاع: Healthcare
الصناعة: Biotechnology
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.